newsfilter
← Latest News
Business Wire·

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will